StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Lifecore Biomedical price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lifecore Biomedical's price to book ratio was 199.3× on Oct 31, 2025, against 17.1× a year earlier. Over the last 5 years it ranged from 0.9× to 210.9×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 2025199.3×+186.0
2024Sep 30, 202413.3×+4.9
2023Jun 30, 20238.4×+5.9
2022Dec 30, 20222.5×+0.8
2021Dec 31, 20211.7×+0.2
2020Dec 31, 20201.5×+0.2
2019Dec 31, 20191.2×−0.1
2018Dec 31, 20181.3×−0.2
2017Dec 29, 20171.5×−0.2
2016Dec 30, 20161.7×+0.3
2015Dec 31, 20151.4×−0.4
2014Dec 31, 20141.8×+0.1
2013Dec 31, 20131.7×+0.2
2012Dec 31, 20121.6×+0.5
2011Dec 30, 20111.0×–

More Lifecore Biomedical figures

See a number that looks wrong?